Predictors of drug-drug interactions of medications prescribed to patients admitted due to suicidal behavior

Abstract

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Patients Who Die by Suicide: A Study of Treatment Patterns and Patient Safety Incidents in Norway

“…The medical doctors who share this kind of treatment responsibility may have extensive workloads—which may contribute to the chance of errors occurring. Errors might be prevented by improving routines for interprofessional collaboration in units, by reducing the workload of the medical doctors, thus allowing more time for follow-up, by improving psychopharmacology training of doctors in training, and by increasing prescribing supervision at the unit—for instance, by involving expert pharmacists in the day-to-day treatment of patients [ 37 , 38 ]. Errors relating to the psychotherapeutic treatment itself could be due to factors such as inadequate initial assessment of the patient or inadequate assessment of changes in the patient’s condition, inadequate psychotherapeutic training or lack of supervision of junior staff, the use of psychotherapeutic approaches that do not meet the patient’s needs, lack of time or continuity in treatment, etc.…”